REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,567,933 | +3.5% | 273,408 | 0.0% | 2.02% | +37.1% |
| Q2 2023 | $7,313,664 | +36.7% | 273,408 | +10.7% | 1.47% | +6.0% |
| Q1 2023 | $5,350,497 | +50.7% | 247,022 | +65.7% | 1.39% | +50.9% |
| Q4 2022 | $3,550,204 | +23.3% | 149,043 | +2.1% | 0.92% | +35.0% |
| Q3 2022 | $2,880,000 | +1.2% | 146,041 | 0.0% | 0.68% | -13.8% |
| Q2 2022 | $2,846,000 | -23.6% | 146,041 | 0.0% | 0.79% | -20.9% |
| Q1 2022 | $3,726,000 | +1.4% | 146,041 | 0.0% | 1.00% | +49.3% |
| Q4 2021 | $3,676,000 | -10.9% | 146,041 | -2.6% | 0.67% | +4.7% |
| Q3 2021 | $4,127,000 | – | 150,000 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,524,031 | $151,966,000 | 28.85% |
| Ponoi II Management, LLC | 685,011 | $18,845,000 | 27.92% |
| Ponoi Management, LLC | 685,011 | $18,845,000 | 16.73% |
| Column Group LLC | 3,347,245 | $92,083,000 | 10.48% |
| TRV GP IV, LLC | 1,419,900 | $39,061,000 | 8.86% |
| Cormorant Asset Management, LP | 3,144,700 | $86,511,000 | 3.52% |
| Boxer Capital, LLC | 3,484,264 | $95,852,000 | 3.35% |
| BVF INC/IL | 2,485,049 | $68,364,000 | 2.67% |
| Casdin Capital, LLC | 2,800,000 | $77,028,000 | 1.92% |
| COMMODORE CAPITAL LP | 226,228 | $6,224,000 | 1.64% |